{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T09:00:13Z","timestamp":1725094813013},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study describes the use of cynomolgus macaques of Chinese origin (CCM) to evaluate the efficacy and immunogenicity of the BCG vaccine against high dose aerosol <jats:italic>Mycobacterium tuberculosis<\/jats:italic> challenge. Progressive disease developed in three of the unvaccinated animals within 10\u00a0weeks of challenge, whereas all six vaccinated animals controlled disease for 26\u00a0weeks. Three unvaccinated animals limited disease progression, highlighting the intrinsic ability of this macaque species to control disease in comparison to macaques of other species and genotypes. Low levels of IFN\u03b3 were induced by BCG vaccination in CCM suggesting that IFN\u03b3 alone does not provide a sufficiently sensitive biomarker of vaccination in this model. An early response after challenge, together with the natural bias towards terminal effector memory T-cell populations and the contribution of monocytes appears to enhance the ability of CCM to naturally control infection. The high dose aerosol challenge model of CCM has value for examination of the host immune system to characterise control of infection which would influence future vaccine design. Although it may not be the preferred platform for the assessment of prophylactic vaccine candidates, the model could be well suited for testing post-exposure vaccination strategies and drug evaluation studies.<\/jats:p>","DOI":"10.1038\/s41598-021-90913-0","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T10:04:33Z","timestamp":1623319473000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation"],"prefix":"10.1038","volume":"11","author":[{"given":"Laura","family":"Sibley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Daykin-Pont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergus","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"#cr-split#-90913_CR1.1","unstructured":"World Health Organization. Global tuberculosis report 2019. https:\/\/apps.who.int\/iris\/handle\/10665\/329368."},{"key":"#cr-split#-90913_CR1.2","unstructured":"License: CC BY-NC-SA 3.0 IGO (2019)"},{"key":"90913_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz, B. B., Fine, P. & Dye, C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness. Lancet 367, 1173\u20131180 (2006).","journal-title":"Lancet"},{"key":"90913_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz, G. A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271, 698\u2013702 (1994).","journal-title":"JAMA"},{"key":"90913_CR4","doi-asserted-by":"publisher","first-page":"e87340","DOI":"10.1371\/journal.pone.0087340","volume":"9","author":"M Tameris","year":"2014","unstructured":"Tameris, M. et al. The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. PLoS ONE 9, e87340 (2014).","journal-title":"PLoS ONE"},{"key":"90913_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01147","volume":"8","author":"NE Nieuwenhuizen","year":"2017","unstructured":"Nieuwenhuizen, N. E. et al. The recombinant bacille Calmette-Gu\u00e9rin vaccine VPM1002: Ready for clinical efficacy testing. Front. Immunol. 8, 1 (2017).","journal-title":"Front. Immunol."},{"key":"90913_CR6","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","volume":"381","author":"DR Tait","year":"2019","unstructured":"Tait, D. R. et al. Final analysis of a trial of M72\/AS01E vaccine to prevent Tuberculosis. N. Engl. J. Med. 381, 2429\u20132439 (2019).","journal-title":"N. Engl. J. Med."},{"key":"90913_CR7","doi-asserted-by":"publisher","first-page":"a018564","DOI":"10.1101\/cshperspect.a018564","volume":"4","author":"CA Scanga","year":"2014","unstructured":"Scanga, C. A. & Flynn, J. L. Modeling tuberculosis in nonhuman primates. Cold Spring Harb. Perspect. Med. 4, a018564 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"90913_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0007-2016","author":"JC Pe\u00f1a","year":"2016","unstructured":"Pe\u00f1a, J. C. & Ho, W. Non-human primate models of Tuberculosis. Microbiol. Spectrum. https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0007-2016 (2016).","journal-title":"Microbiol. Spectrum."},{"key":"90913_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0684.2012.00536.x","volume":"41","author":"D Kaushal","year":"2012","unstructured":"Kaushal, D., Mehra, S., Didier, P. J. & Lackner, A. A. The non-human primate model of tuberculosis. J. Med. Primatol. 41, 191\u2013201 (2012).","journal-title":"J. Med. Primatol."},{"key":"90913_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nm0496-430","volume":"2","author":"GP Walsh","year":"1996","unstructured":"Walsh, G. P. et al. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat. Med. 2, 430\u2013436 (1996).","journal-title":"Nat. Med."},{"key":"90913_CR11","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","volume":"71","author":"SV Capuano","year":"2003","unstructured":"Capuano, S. V. et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis Infection. Infect. Immun. 71, 5831\u20135844 (2003).","journal-title":"Infect. Immun."},{"key":"90913_CR12","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1128\/IAI.00592-09","volume":"77","author":"PL Lin","year":"2009","unstructured":"Lin, P. L. et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77, 4631\u20134642 (2009).","journal-title":"Infect. Immun."},{"key":"90913_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00776-17","author":"DJ Laddy","year":"2018","unstructured":"Laddy, D. J. et al. Toward tuberculosis vaccine development: Recommendations for nonhuman primate study design. Infect. Immun. https:\/\/doi.org\/10.1128\/IAI.00776-17 (2018).","journal-title":"Infect. Immun."},{"key":"90913_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","volume":"577","author":"PA Darrah","year":"2020","unstructured":"Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95\u2013102 (2020).","journal-title":"Nature"},{"key":"90913_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.4473","volume":"24","author":"SG Hansen","year":"2018","unstructured":"Hansen, S. G. et al. Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine. Nat. Med. 24, 130\u2013143 (2018).","journal-title":"Nat. Med."},{"key":"90913_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-020-00262-8","volume":"6","author":"AD White","year":"2021","unstructured":"White, A. D. et al. OPEN MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies. Npj Vaccines 6, 1\u201310 (2021).","journal-title":"Npj Vaccines"},{"key":"90913_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tube.2015.11.004","volume":"96","author":"L Sibley","year":"2016","unstructured":"Sibley, L. et al. Route of delivery to the airway influences the distribution of pulmonary disease but not the outcome of Mycobacterium tuberculosis infection in rhesus macaques. Tuberculosis (Edinb.) 96, 141\u2013149 (2016).","journal-title":"Tuberculosis (Edinb.)"},{"key":"90913_CR18","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/IAI.69.4.2666-2674.2001","volume":"69","author":"AA Chackerian","year":"2001","unstructured":"Chackerian, A. A., Perera, T. V. & Behar, S. M. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69, 2666\u20132674 (2001).","journal-title":"Infect. Immun."},{"key":"90913_CR19","doi-asserted-by":"publisher","first-page":"e1000392","DOI":"10.1371\/journal.ppat.1000392","volume":"5","author":"CY Chen","year":"2009","unstructured":"Chen, C. Y. et al. A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog. 5, e1000392 (2009).","journal-title":"PLoS Pathog."},{"key":"90913_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder, R. A., Darrah, P. A. & Roederer, M. T-cell quality in memory and protection: Implications for vaccine design. Nat. Rev. Immunol. 8, 247\u2013258 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"90913_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","volume":"101","author":"S Sharpe","year":"2016","unstructured":"Sharpe, S. et al. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations. Tuberculosis 101, 174\u2013190 (2016).","journal-title":"Tuberculosis"},{"key":"90913_CR22","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/eji.201040455","volume":"40","author":"N Caccamo","year":"2010","unstructured":"Caccamo, N. et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol. 40, 2211\u20132220 (2010).","journal-title":"Eur. J. Immunol."},{"key":"90913_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jinf.2014.06.009","volume":"69","author":"T Chiacchio","year":"2014","unstructured":"Chiacchio, T. et al. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J. Infect. 69, 533\u2013545 (2014).","journal-title":"J. Infect."},{"key":"90913_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/794962","volume":"2013","author":"BS Ahamed Kabeer","year":"2013","unstructured":"Ahamed Kabeer, B. S., Selvaraj, A. & Raja, A. Increased frequency of antigen-specific polyfunctional T cells in tuberculosis patients. ISRN Immunol. 2013, 1\u20138 (2013).","journal-title":"ISRN Immunol."},{"key":"90913_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13, 843\u2013850 (2007).","journal-title":"Nat. Med."},{"key":"90913_CR26","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","volume":"182","author":"T Lindenstr\u00f8m","year":"2009","unstructured":"Lindenstr\u00f8m, T. et al. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J. Immunol. 182, 8047\u20138055 (2009).","journal-title":"J. Immunol."},{"key":"90913_CR27","doi-asserted-by":"publisher","first-page":"e5930","DOI":"10.1371\/journal.pone.0005930","volume":"4","author":"C Aagaard","year":"2009","unstructured":"Aagaard, C. et al. Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31\u00ae against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS ONE 4, e5930 (2009).","journal-title":"PLoS ONE"},{"key":"90913_CR28","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1016\/j.vaccine.2016.09.002","volume":"34","author":"SG Smith","year":"2016","unstructured":"Smith, S. G., Zelmer, A., Blitz, R., Fletcher, H. A. & Dockrell, H. M. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants. Vaccine 34, 5298\u20135305 (2016).","journal-title":"Vaccine"},{"key":"90913_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","volume":"182","author":"BMN Kagina","year":"2010","unstructured":"Kagina, B. M. N. et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Gu\u00e9rin vaccination of newborns. Am. J. Respir. Crit. Care Med. 182, 1073\u20131079 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"90913_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01262","author":"DA Lewinsohn","year":"2017","unstructured":"Lewinsohn, D. A., Lewinsohn, D. M. & Scriba, T. J. Polyfunctional CD4+ T cells as targets for tuberculosis vaccination. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01262 (2017).","journal-title":"Front. Immunol."},{"key":"90913_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1128\/CVI.00690-12","volume":"20","author":"AD White","year":"2013","unstructured":"White, A. D. et al. Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques. Clin. Vaccine Immunol. 20, 663\u2013672 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"90913_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/pharmaceutics12050394","volume":"12","author":"AD White","year":"2020","unstructured":"White, A. D. et al. Protective efficacy of inhaled BCG vaccination against ultra-low dose aerosol M. tuberculosis challenge in Rhesus Macaques. Pharmaceutics 12, 394 (2020).","journal-title":"Pharmaceutics"},{"key":"90913_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tube.2015.10.004","volume":"96","author":"S Sharpe","year":"2016","unstructured":"Sharpe, S. et al. Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques. Tuberculosis 96, 1\u201312 (2016).","journal-title":"Tuberculosis"},{"key":"90913_CR34","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1128\/CVI.00079-10","volume":"17","author":"SA Sharpe","year":"2010","unstructured":"Sharpe, S. A. et al. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin. Vaccine Immunol. 17, 1170\u20131182 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"90913_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1017\/S0022172400041851","volume":"67","author":"HA Druett","year":"1969","unstructured":"Druett, H. A. A mobile form of the Henderson apparatus. J. Hyg. (Lond.) 67, 437\u2013448 (1969).","journal-title":"J. Hyg. (Lond.)"},{"key":"90913_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2672.2011.05069.x","volume":"111","author":"SO Clark","year":"2011","unstructured":"Clark, S. O., Hall, Y., Kelly, D. L. F., Hatch, G. J. & Williams, A. Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models. J. Appl. Microbiol. 111, 350\u2013359 (2011).","journal-title":"J. Appl. Microbiol."},{"key":"90913_CR37","doi-asserted-by":"publisher","first-page":"e0171906","DOI":"10.1371\/journal.pone.0171906","volume":"12","author":"SA Sharpe","year":"2017","unstructured":"Sharpe, S. A. et al. An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques. PLoS ONE 12, e0171906 (2017).","journal-title":"PLoS ONE"},{"key":"90913_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1017\/S0022172400039504","volume":"60","author":"GJ Harper","year":"1962","unstructured":"Harper, G. J. & Morton, J. D. A method for measuring the retained dose in experiments on airborne infection. J. Hyg. (Lond.) 60, 249\u2013257 (1962).","journal-title":"J. Hyg. (Lond.)"},{"key":"90913_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.tube.2009.09.002","volume":"89","author":"SA Sharpe","year":"2009","unstructured":"Sharpe, S. A. et al. Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis. Tuberculosis 89, 405\u2013416 (2009).","journal-title":"Tuberculosis"},{"key":"90913_CR40","first-page":"161","volume-title":"The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models","author":"C Kleiveland","year":"2015","unstructured":"Kleiveland, C. & Kleiveland, C. Peripheral blood mononuclear cells. In The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models (eds Verhoeckx, K. et al.) 161\u2013167 (Springer, 2015)."},{"key":"90913_CR41","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3389\/fimmu.2019.02983","volume":"10","author":"R Tanner","year":"2020","unstructured":"Tanner, R. et al. Tools for assessing the protective efficacy of TB vaccines in humans: In vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection. Front. Immunol. 10, 2983 (2020).","journal-title":"Front. Immunol."},{"key":"90913_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00263-7","author":"R Tanner","year":"2021","unstructured":"Tanner, R. et al. OPEN: A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates. Npj Vaccines. https:\/\/doi.org\/10.1038\/s41541-020-00263-7 (2021).","journal-title":"Npj Vaccines."},{"key":"90913_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.21015","volume":"79","author":"M Roederer","year":"2011","unstructured":"Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytom. A J. Int. Soc. Anal. Cytol. 79, 167\u2013174 (2011).","journal-title":"Cytom. A J. Int. Soc. Anal. Cytol."},{"key":"90913_CR44","doi-asserted-by":"publisher","first-page":"11497","DOI":"10.1073\/pnas.201404898","volume":"98","author":"JAM Langermans","year":"2001","unstructured":"Langermans, J. A. M. et al. Divergent effect of bacillus Calmette-Gu\u00e9rin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: Implications for primate models in tuberculosis vaccine research. Proc. Natl. Acad. Sci. U.S.A. 98, 11497\u201311502 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"90913_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1172\/JCI46252","volume":"122","author":"PL Lin","year":"2012","unstructured":"Lin, P. L. et al. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J. Clin. Investig. 122, 303\u2013314 (2012).","journal-title":"J. Clin. Investig."},{"key":"90913_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tube.2007.10.001","volume":"88","author":"RE Weir","year":"2008","unstructured":"Weir, R. E. et al. Comparison of IFN-\u03b3 responses to mycobacterial antigens as markers of response to BCG vaccination. Tuberculosis 88, 31\u201338 (2008).","journal-title":"Tuberculosis"},{"key":"90913_CR47","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.tube.2008.06.005","volume":"88","author":"NER Beveridge","year":"2008","unstructured":"Beveridge, N. E. R. et al. A comparison of IFN\u03b3 detection methods used in tuberculosis vaccine trials. Tuberculosis 88, 631\u2013640 (2008).","journal-title":"Tuberculosis"},{"key":"90913_CR48","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","volume":"33","author":"AKK Luabeya","year":"2015","unstructured":"Luabeya, A. K. K. et al. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Vaccine 33, 4130\u20134140 (2015).","journal-title":"Vaccine"},{"key":"90913_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10096-005-1377-8","volume":"24","author":"T Meier","year":"2005","unstructured":"Meier, T., Eulenbruch, H.-P., Wrighton-Smith, P., Enders, G. & Regnath, T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 24, 529\u2013536 (2005).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"90913_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02479","volume":"10","author":"K Dijkman","year":"2019","unstructured":"Dijkman, K. et al. Disparate tuberculosis disease development in macaque species is associated with innate immunity infection. Front. Immunol. 10, 1\u201318 (2019).","journal-title":"Front. Immunol."},{"key":"90913_CR51","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1038\/s41598-019-39819-6","volume":"9","author":"L Sibley","year":"2019","unstructured":"Sibley, L. et al. Differences in monocyte:lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques. Sci. Rep. 9, 3340 (2019).","journal-title":"Sci. Rep."},{"key":"90913_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00505-17","author":"P Maiello","year":"2018","unstructured":"Maiello, P. et al. Rhesus macaques are more susceptible to progressive tuberculosis than cynomolgus macaques: A quantitative comparison. Infect. Immun. https:\/\/doi.org\/10.1128\/IAI.00505-17 (2018).","journal-title":"Infect. Immun."},{"key":"90913_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/QAI.0000000000000353","volume":"67","author":"V Naranbhai","year":"2015","unstructured":"Naranbhai, V. et al. The association between the ratio of monocytes:lymphocytes and risk of tuberculosis (TB) amongst HIV infected postpartum women. J. Acquir. Immune Defic. Syndr. 67, 573\u2013575 (2015).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"90913_CR54","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/infdis\/jit494","volume":"209","author":"V Naranbhai","year":"2014","unstructured":"Naranbhai, V. et al. Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy. J. Infect. Dis. 209, 500\u2013509 (2014).","journal-title":"J. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90913-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90913-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90913-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:34:00Z","timestamp":1670060040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90913-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90913"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90913-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12274"}}